Josephine A. Lucero
Taft Avenue
Manila, 1000, Philippines
Manila, 1000, Philippines
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.
Journal: Leukemia
Published: February 16, 2024
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.
Journal: Annals of hematology
Published: September 21, 2023
Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS).
Journal: Current oncology (Toronto, Ont.)
Published: May 11, 2023
A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment.
Journal: Current hematologic malignancy reports
Published: April 20, 2023
A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer.
Journal: Cancer treatment and research communications
Published: July 14, 2022
The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development.
Journal: OncoTargets and therapy
Published: December 14, 2020
Revisiting a lower starting dose of alectinib in ALK-Positive non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: December 11, 2020
What Will Keep Me Coming Back to the Clinic: Factors Identified by Filipino Colorectal Cancer Patients Seen at a National Academic Referral Center.
Journal: Journal of patient experience
Published: October 16, 2020
White islands in a sea of red: A tropical rash.
Journal: European journal of internal medicine
Published: January 23, 2019
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis.
Journal: OncoTargets and therapy
Published: March 06, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026